Reply: Low-dose glucocorticoids in rheumatoid arthritis: blurring the line between therapeutic dose and substitution therapy?

Yannick Palmowski, Maarten Boers, Frank Buttgereit

Research output: Contribution to journalComment/Letter to the editorAcademic


We would like to thank Masi and colleagues for their interest in our paper as well as for the interesting comments regarding the potential usefulness of neuroendocrine immune (NEI) testing in patients with rheumatoid arthritis (RA). When the first patient with rheumatoid arthritis (RA) was treated with glucocorticoids (GCs) in 1948, the effect was just overwhelming for that time. This article is protected by copyright. All rights reserved.

Original languageEnglish
Pages (from-to)577-578
JournalArthritis care & research
Issue number4
Early online date26 Oct 2017
Publication statusPublished - 1 Apr 2019


  • Journal Article

Cite this